Currently there is no standardization
of PRP or BMA in which to rate procedures for adequate and
effective results. It you are to have a good outcome then
you must know in advance who's system is working and who's
may be questionable. The only science that can be relied
on currently is "concentrate levels based of percentage
of volume" i.e. the stronger the concentrate levels,
the higher the positive outcome.“The system" (procedure
and supplies) distributed by RS Biologics for the BMA /
PRP procedure is the Only system with acceptable concentrate
levels and 3rd party, independent studies to back it up.
Moreover here are large medical supply companies that have
come to the market with inferior Platelet Rich Plasma product
and procedures and while they are claiming their systems
are several multiples above baseline standard (please read
definition for “baseline standard”) for showing some results
the concentrate levels are not sufficient to treat many
conditions effectively and with good positive outcomes.
Analogy - Imagine for a moment, you have
your dream sports car or that new boat. Written in the owners
manual at the bottom of the glove box it says, “only use
High Octane fuel, Ethanol will not burn (produce) with enough
efficiency needed for this engine.” So, somewhat uneducated
about the DIFFERENCES in fuel process refining you pull
up to the first pump and fill it up with Regular as you
usually do. Without understanding the outcome, your driving
or owning experience is dampened by rough starts, hesitant
acceleration, awful performance and low gas mileage. In
effect you have used a refining process that offers poor
concentrate results.
Does this make all Gas Bad ? Do you turn your back on the
industry ? Make unfounded claims such as, “ahhh that technology
is more wishful thinking than true science.” Or “It’s only
been around since the seventies and I need some strong 10
year studies before I will consider it again.” ? Are you
throwing out the baby with the bath water or just refusing
to get educated ? The same holds true for PRP and BMA, The
refining (harvesting and processing) varies from 28% concentrate
(2X or 3X above baseline standard) up to almost 85% concentrate
(9X to 11X above baseline standard). The latter is the system
we distribute. Is there any wonder why two people can receive
treatment for the same condition and report vastly different
results ?
All PRP / BMA systems are not created equal.
As stated above, many companies have rushed to market with
seemingly strong multiples above baseline in which their
street reps waive around claiming victory. And while their
stories may have some science behind them the truth is,
unless the physician utilizes the strongest concentrate
of live plates the outcome of the procedure may be seriously
in question.
Platelet Rich Plasma Platelets and Mesenchymal Stem Cells
(delivered within platelets) are extremely fragile and can
die easily or before they are re-injected into an afflicted
site. It is estimated even with the gentlest of blood draws
as much as 10% can be lost. Now add in rough push or pull
by a technician creating a vortex within the syringe and
more if not all can be killed. Or centrifuges that may not
be properly designed for the purpose of preserving platelets
and simply spins with a separation at the heart of the design
can kill or substantially wipe out the remaining majority.
After all this, what is being injected ? Is there any wonder
why one study will have 85% positive results and be touted
as the fountain of youth within your own body while other
study of the same condition using poor procedure will claim
little or no effect.
Mesenchymal stem cells have the potential to differentiate
in to many types of tissue such as Bone, soft tissue, tendon,
cartilage and ligaments with even higher prospects of veins,
arteries and other vascular affected areas of the body.
To utilize all the healing potential of mesenchymal stem
cells, the Platelet Rich Plasma PRP or BMA can be concentrated
using a specially programmed centrifuge system. Centrifugation
reduces the volume of concentrated buffycoat cells needed
to inject in the site, but still maintains a high amount
of concentrated cells.
The buffycoat layer obtained from centrifugation contains
stem cells as well as other total nucleated cells, which
have osteogenic and immediate rejuvenation effects that,
influence healing and repair to the site.
Why Does There
Seem To Be Inconsistent Outcomes with Platelet Rich Plasma
?
Please read the FUEL | PRP Analogy.
This should not be a surprise if you have read the balance
of this page. Inconsistent PRP or BMA outcomes is 95% of
the time due to miss use of the buffycoat during the procedure.
This could be a badly designed procedure, rough handling
of blood during the procedure, poorly designed centrifuge,
aggressive transfer of blood causing a vortex within the
syringe or other means that can kill the valuable buffycoat.
Our system for producing Platelet Rich Plasma produces
the highest concentrate of platelets available. Don't just
take our word for it, read the independent study produced
when we received our 510k approval. It states, "the
system consistently produces more than 80% concentrate and
many times more than 80%". That’s right, to date we
have the only know white papers proving these numbers. This
simply means, if positive outcomes and patient well being
is or are important to you then you need only our system.
Why Is Our Platelet Rich Plasma or BMA System The
Right Choice ?
Our Platelet Rich Plasma and Bone Marrow Concentrate System/s
are improving a quickly growing, vast array of medical outcomes
by offering high-quality cell yields (highest concentrate
of buffycoat known in white papers.) through gentle centrifugation,
which preserves the fragile buffycoat layer.
The system sets itself apart by providing a single spin,
closed-system operation reducing processing steps and improving
concentrate levels and outcomes. This easy-to-use system
provides a fast and convenient method for concentrating
cells in the OR and or office and clinic, while reducing
a patient’s risk of infection and improving outcomes
